OasisLMS

This program brings together members of the nephrology care team to discuss the cutting edge of rapidly advancing diabetes technologies and treatments. Diabetes is the most common cause of CKD and kidney failure requiring dialysis or kidney transplantation. Continuous glucose monitoring (CGM), insulin pumps, and closed-loop technology (automated insulin delivery [AID]) have revolutionized diabetes care. New drug classes are also available to treat diabetes and reduce CKD-related complications, including progression to kidney failure and cardiovascular disease.

Nephrology care teams are well positioned to help implement new diabetes treatments according to current guidelines. Nephrology care teams often assume comprehensive care for patients with complex disease, including those with advanced CKD, kidney failure, and kidney transplants. Since many of these patients have diabetes, optimal diabetes management is an important part of their care. Given the presentation of type 1 diabetes in adults and type 2 diabetes in the pediatric population and the discovery of atypical forms of diabetes, correct diabetes classification is imperative because the treatment strategies differ depending on the etiology.

Learning Objectives
Upon completion of the program, the participant will be able to:

• Describe diabetes diagnosis, classification, and assessment
• Discuss current technology and interpretation of CGM
• Explain how and for whom to prescribe new diabetes drugs
• Describe how CGM and new treatments can be used for patients with diabetes and various stages of CKD

Target Audience

• Physicians
• Researchers
• Medical and Other Trainees
• Nurses and Nurse Practitioners
• Pharmacists
• Physician Assistants
• Other Healthcare Professionals

Commercial Support
ASN thanks Abbott Diabetes Care Inc. and Dexcom for in-kind support (continuous glucose monitoring sensors).

Privacy Policy/Confidentiality
http://www.asn-online.org/terms/privacy.aspx    
    
ASN Medical Disclaimer     
http://www.asn-online.org/terms/medical-disclaimer.aspx

Please note that only learners who participated in this Early Program in-person in Houston can claim credits.

Accreditation Statement

In support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

AMA Credit Designation Statement – Physicians:
The American Society of Nephrology designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation Statement – Nurses: This CE activity is approved for 6.50 ANCC contact hours. 

ACPE Credit Designation Statement – Pharmacists: This CE activity is approved for 6.50 pharmacy contact hours.

NCCPA Credit Designation Statement – Physician Assistants:
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society.
Physician Assistants may receive a Certificate of Participation that states this activity has been approved for up to 6.50 AMA PRA Category 1 Credits™.

CME/CNE/CPE Deadline Date: December 17, 2025 at 11:59 PM ET
Estimated Time for Completion: 6.50 hours

Method of Participation

1. Participate in the Early Program (verification required).
2. In the activity, click the Questionnaire tab, and complete the Demographics Questionnaire.
3. Complete the General Evaluation.
4. Select the Claim Credit tab. Use the Credit Selection dropdown to select your applicable credit type. If none apply, select None of the Above - Print Participation Certificate.
   1. If a CE credit type is selected:
      1. The number of credits defaults to the maximum amount. Adjust based on your actual participation. 
      2. Select the Claim button.
      3. Select the View Certificate button. It may take up to 15 minutes for your certificate to show.
   2. If None of the Above - Print Participation Certificate is selected:
      1. Select I understand the above - continue to participation certificate.
      2. Select Get Certificate.

Co-Chair(s)

• Ian de Boer, MD, MS
• Joshua J. Neumiller, PharmD

A full faculty listing is available here. 

ASN Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ASN requires all individuals in a position to control content for Kidney Week Early Programs to disclose all financial relationships with ineligible companies.

All disclosed financial relationships were reviewed by ASN. Any relevant financial relationships with ineligible companies were identified and mitigated prior to the activity.

View the ASN Disclosure Policy here.

• Broadband cable, DSL, or high-speed internet connection
• Please use the latest version of Google Chrome for the best viewing experience. Mozilla and Safari can also be used; however, Microsoft Edge is not recommended. Please check the ASN auto-detect settings page.
• 533 MHz or faster processor
• 512 MB RAM or higher
• Adobe Reader (free download)
• Computer which can play MP3 files
• Apple iPad/iPhone running HTML5
• Android devices